×
About 799 results

ALLMedicine™ Nail Psoriasis Center

Research & Reviews  377 results

One year in review 2019: psoriatic arthritis.
https://www.ncbi.nlm.nih.gov/pubmed/33253102
Clinical and Experimental Rheumatology; Calabresi E, Monti S et. al.

Nov 30th, 2020 - Psoriatic arthritis (PsA) is an inflammatory arthritis belonging to spondyloarthritides (SpA), a group of rheumatologic diseases characterised bya wide spectrum of different clinical manifestations that tend to associate with various comorbidities...

Intralesional methotrexate in dermatology: Diverse indications and practical considerat...
https://doi.org/10.1111/dth.14404
Dermatologic Therapy REFERENCES; Searle T, Ali FR et. al.

Oct 12th, 2020 - Intralesional methotrexate (IL-MTX) is a long-established treatment, which is arguably underutilized by dermatologists. We describe the underlying evidence base and practical considerations for its broad range of cutaneous indications, including i...

Tofacitinib for the Treatment of Nail Lesions and Palmoplantar Pustulosis in Synovitis,...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527944
JAMA Dermatology; Li C, Li Z et. al.

Sep 30th, 2020 - Nail involvement is common in synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome, which has a strong association with quality of life in patients with SAPHO. Tofacitinib is an oral Janus kinase inhibitor that has been previou...

Psoriatic patients undergoing long-term therapy with biologics: Impact of residual loca...
https://doi.org/10.1111/dth.14337
Dermatologic Therapy REFERENCES; Muslimani MA, Bolcato V et. al.

Sep 25th, 2020 - Residual psoriasis characterizes body sites resistant to biologic drugs. Some affected body sites exert disproportionate impact on patients' quality of life. The aim was to localize residual psoriasis in patients treated with biologics for at leas...

Clinical parameters associated with severity of nail psoriasis and therapeutic efficacy.
https://doi.org/10.1684/ejd.2020.3841
European Journal of Dermatology : EJD; You Z, Yang H et. al.

Sep 24th, 2020 - Nail involvement is common in psoriasis patients, however, there are few detailed studies of clinical parameters related to disease severity and therapeutic efficacy. Our retrospective study aimed to describe the prevalence and clinical characteri...

see more →

Guidelines  2 results

Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients
http://www.eurekaselect.com/160466/article
Reviews on Recent Clinical Trials;

Nov 29th, 2018 - Background: Psoriatic arthritis is a chronic inflammatory arthropathy that affects 14%- 30% of patients with skin and/or nail psoriasis, leading to severe physical limitations and disability. It has been included in the group of spondyloarthropath...

Treatment of nail psoriasis: best practice recommendations from the Medical Board of th...
https://doi.org/10.1001/jamadermatol.2014.2983
JAMA Dermatology; Crowley JJ, Weinberg JM et. al.

Dec 4th, 2014 - Nail psoriasis can be difficult to treat and has a significant effect on quality of life. Relatively few controlled trials evaluating treatments for nail psoriasis have been published. There is an unmet need for treatment recommendations to guide ...

see more →

Clinicaltrials.gov  387 results

One year in review 2019: psoriatic arthritis.
https://www.ncbi.nlm.nih.gov/pubmed/33253102
Clinical and Experimental Rheumatology; Calabresi E, Monti S et. al.

Nov 30th, 2020 - Psoriatic arthritis (PsA) is an inflammatory arthritis belonging to spondyloarthritides (SpA), a group of rheumatologic diseases characterised bya wide spectrum of different clinical manifestations that tend to associate with various comorbidities...

Intralesional methotrexate in dermatology: Diverse indications and practical considerat...
https://doi.org/10.1111/dth.14404
Dermatologic Therapy REFERENCES; Searle T, Ali FR et. al.

Oct 12th, 2020 - Intralesional methotrexate (IL-MTX) is a long-established treatment, which is arguably underutilized by dermatologists. We describe the underlying evidence base and practical considerations for its broad range of cutaneous indications, including i...

Tofacitinib for the Treatment of Nail Lesions and Palmoplantar Pustulosis in Synovitis,...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527944
JAMA Dermatology; Li C, Li Z et. al.

Sep 30th, 2020 - Nail involvement is common in synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome, which has a strong association with quality of life in patients with SAPHO. Tofacitinib is an oral Janus kinase inhibitor that has been previou...

Psoriatic patients undergoing long-term therapy with biologics: Impact of residual loca...
https://doi.org/10.1111/dth.14337
Dermatologic Therapy REFERENCES; Muslimani MA, Bolcato V et. al.

Sep 25th, 2020 - Residual psoriasis characterizes body sites resistant to biologic drugs. Some affected body sites exert disproportionate impact on patients' quality of life. The aim was to localize residual psoriasis in patients treated with biologics for at leas...

Clinical parameters associated with severity of nail psoriasis and therapeutic efficacy.
https://doi.org/10.1684/ejd.2020.3841
European Journal of Dermatology : EJD; You Z, Yang H et. al.

Sep 24th, 2020 - Nail involvement is common in psoriasis patients, however, there are few detailed studies of clinical parameters related to disease severity and therapeutic efficacy. Our retrospective study aimed to describe the prevalence and clinical characteri...

see more →

News  29 results

Nail Psoriasis Tips
https://www.mdedge.com/dermatology/article/194086/hair-nails/nail-psoriasis-tips?channel=219
Jeffrey M. Weinberg, MD

Feb 7th, 2019 - What does your patient need to know at the first visit? Patient education is important initially. There are several causes for nail dystrophy.

Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients
http://www.eurekaselect.com/160466/article
Reviews on Recent Clinical Trials;

Nov 29th, 2018 - Background: Psoriatic arthritis is a chronic inflammatory arthropathy that affects 14%- 30% of patients with skin and/or nail psoriasis, leading to severe physical limitations and disability. It has been included in the group of spondyloarthropath...

Pearls in Dermatology: 2017
https://www.mdedge.com/dermatology/article/154300/psoriasis/pearls-dermatology-2017

Jan 18th, 2018 - The Pearls in Dermatology collection consists of our popular pearls from the year in one convenient file. Topics include: Nail psoriasis and psoriasis on the hands and feet Genital wart treatment Isotretinoin for acne Cosmeceuticals for rosacea Su.

Clinical Pearl: Early Diagnosis of Nail Psoriasis and Psoriatic Arthritis
https://www.mdedge.com/dermatology/article/130683/psoriasis/clinical-pearl-early-diagnosis-nail-psoriasis-and-psoriatic
Shari R. Lipner, MD, PhD, Matilde Iorizzo, MD, PhD

Feb 3rd, 2017 - Practice Gap Early diagnosis of nail psoriasis is challenging because nail changes, including pitting, subungual hyperkeratosis, crumbling, oil spots, salmon patches, onycholysis, and splinter hemorrhages, may be subtle and nonspecific. Furthermor.

Nail Psoriasis Diagnosis and Treatment Recommendations
https://www.mdedge.com/dermatology/article/102646/psoriasis/nail-psoriasis-diagnosis-and-treatment-recommendations
Antonella Tosti, MD

Sep 25th, 2015 - Clinical diagnosis of nail psoriasis may be difficult, as many of its symptoms are seen in other nail disorders. To ensure accurate diagnosis, it is important to recognize the characteristic signs of nail psoriasis and clarify which part of the na.

see more →

Patient Education  4 results see all →